Accord Healthcare

Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
 

DRUG
REACTION
REPORT

report

GROWTH’S IN OUR NATURE

Accord Healthcare is one of the fastest growing generic pharmaceutical companies in Ireland and the UK.

Acquiring Actavis Ireland and the UK in 2017 facilitates Accord’s ambition of becoming a top 5 pan-EMEA generics company by 2020 and a leading player in the industry at European level.

01

TRULY MULTINATIONAL

Accord has one of the most extensive sales, marketing and distribution networks in Europe. Headquartered from UK, Accord now supplies products in close to 65 EMENA markets.

02

A COMPLETE APPROACH

Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.

 

03

EUROPEAN FOCUS

Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.

04

News

06-07-2018

Precautionary recall of some Valsartan blood pressure and heart medicines

The Health Products Regulatory Authority (HPRA) have alerted Actavis Ireland Limited (part of the Accord Healthcare group) that there is a potential impurity issue with the supply of Valsartan active substance from a third-party facility.

14-06-2018

Accord Innovation in Aseptic Compounding Award

Accord Ireland were proud to once again support the “Accord Innovation in Aseptic Compounding Award” at the annual Hospital Pharmacy Awards event, which took place in Dublin recently.

We congratulate the aseptic compounding team from Beaumont Hospital in Dublin who won the award.